Literature DB >> 15379715

Plasminogen activator inhibitor-1.

Ann Gils1, Paul J Declerck.   

Abstract

Plasminogen activator inhibitor-1 (PAI-1) is an important component of the plasminogen/plasmin system as it is the main inhibitor of tissue-type and urokinase-type plasminogen activator. Consequently, PAI-1 plays an important role in cardiovascular diseases (mainly through inhibition of t-PA) and in cell migration and tumor development (mainly through inhibition of u-PA). As a member of the serpin superfamily, PAI-1 shares important structural properties with other serpins. However, PAI-1 also exhibits unique conformational and functional properties. The current paper provides an overview of the knowledge on PAI-1 gathered since its discovery two decades ago. We are discussing (a) its structural properties and their subsequent association with the functional properties, (b) its role in a wide variety of (patho)physiological processes and (c) a number of strategies to interfere with its functional properties eventually aiming at pharmacological modulation of this risk factor.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15379715     DOI: 10.2174/0929867043364595

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  22 in total

1.  Habitual consumption of coffee and green tea in relation to serum adipokines: a cross-sectional study.

Authors:  Ngoc Minh Pham; Akiko Nanri; Kazuki Yasuda; Kayo Kurotani; Keisuke Kuwahara; Shamima Akter; Masao Sato; Hitomi Hayabuchi; Tetsuya Mizoue
Journal:  Eur J Nutr       Date:  2014-04-22       Impact factor: 5.614

2.  Functional behavior and gene expression of magnetic nanoparticle-loaded primary endothelial cells for targeting vascular stents.

Authors:  Fatema Tuj Zohra; Mikhail Medved; Nina Lazareva; Boris Polyak
Journal:  Nanomedicine (Lond)       Date:  2015-05       Impact factor: 5.307

3.  Inhibition of PAI-1 antiproteolytic activity against tPA by RNA aptamers.

Authors:  Jared Damare; Stephanie Brandal; Yolanda M Fortenberry
Journal:  Nucleic Acid Ther       Date:  2014-06-12       Impact factor: 5.486

4.  Regulation of plasminogen activator inhibitor-1 expression in endothelial cells with exposure to metal nanoparticles.

Authors:  Min Yu; Yiqun Mo; Rong Wan; Sufan Chien; Xing Zhang; Qunwei Zhang
Journal:  Toxicol Lett       Date:  2010-02-18       Impact factor: 4.372

5.  Plasminogen activator inhibitor-1 polymorphisms (-844 G>A and HindIII C>G) in systemic lupus erythematosus: association with clinical variables.

Authors:  Jorge Ramón Padilla-Gutiérrez; Claudia Azucena Palafox-Sánchez; Yeminia Valle; Gerardo Orozco-Barocio; Edith Oregón-Romero; Mónica Vázquez-Del Mercado; Héctor Rangel-Villalobos; Mara Anaís Llamas-Covarrubias; José Francisco Muñoz-Valle
Journal:  Clin Exp Med       Date:  2010-06-22       Impact factor: 3.984

6.  Targeting plasminogen activator inhibitor-1 in tetracycline-induced pleural injury in rabbits.

Authors:  Galina Florova; Ali O Azghani; Sophia Karandashova; Chris Schaefer; Serge V Yarovoi; Paul J Declerck; Douglas B Cines; Steven Idell; Andrey A Komissarov
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-08-31       Impact factor: 5.464

7.  Role of the TMPRSS2-ERG gene fusion in prostate cancer.

Authors:  Scott A Tomlins; Bharathi Laxman; Sooryanarayana Varambally; Xuhong Cao; Jindan Yu; Beth E Helgeson; Qi Cao; John R Prensner; Mark A Rubin; Rajal B Shah; Rohit Mehra; Arul M Chinnaiyan
Journal:  Neoplasia       Date:  2008-02       Impact factor: 5.715

8.  Inhibition of plasminogen activator inhibitor-1 expression in vascular smooth muscle cells by protoporphyrins through a heme oxygenase-independent mechanism.

Authors:  Xilin Long; Andrew I Schafer
Journal:  Mol Cell Biochem       Date:  2008-03-16       Impact factor: 3.396

9.  The -844 G/A PAI-1 polymorphism is associated with mRNA expression in rheumatoid arthritis.

Authors:  Nora Magdalena Torres-Carrillo; Norma Torres-Carrillo; Mónica Vázquez-Del Mercado; Vidal Delgado-Rizo; Edith Oregón-Romero; Isela Parra-Rojas; José Francisco Muñoz-Valle
Journal:  Rheumatol Int       Date:  2007-09-26       Impact factor: 2.631

10.  Functional structure of the somatomedin B domain of vitronectin.

Authors:  Aiwu Zhou
Journal:  Protein Sci       Date:  2007-06-13       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.